Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy

Background: We conducted this study to investigate adverse pregnancy outcomes of hepatitis B virus infection coexistng with intrahepatic cholestasis in pregnant women, along with identifying associated risk factors. Methods: We retrospectively collected study data from Beijing Youan Hospital in Chin...

Full description

Saved in:
Bibliographic Details
Main Authors: Chong Zhang, Hong Wei, Zhiqiang Zhao, Yunxia Zhu
Format: Article
Language:English
Published: IMR Press 2024-02-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/51/2/10.31083/j.ceog5102036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763832161894400
author Chong Zhang
Hong Wei
Zhiqiang Zhao
Yunxia Zhu
author_facet Chong Zhang
Hong Wei
Zhiqiang Zhao
Yunxia Zhu
author_sort Chong Zhang
collection DOAJ
description Background: We conducted this study to investigate adverse pregnancy outcomes of hepatitis B virus infection coexistng with intrahepatic cholestasis in pregnant women, along with identifying associated risk factors. Methods: We retrospectively collected study data from Beijing Youan Hospital in China spanning January 2014 to December 2021. The study included 220 patients, divided into two groups: Group I consisted of 110 patients with hepatitis B virus infection and intrahepatic cholestasis during pregnancy, while Group II comprised 110 patients with hepatitis B virus infection alone. Maternal demographics, laboratory values, obstetric complications, and adverse pregnancy outcomes were collected and analyzed between Groups I and II. To investigate the features of hepatitis B virus infection with intrahepatic cholestasis in pregnancy patients further, we also evaluated risk factors of adverse pregnancy outcomes in Group I. Results: Adverse pregnancy outcomes, including preterm birth (<37 weeks (w)), postpartum hemorrhage, meconium-stained amniotic fluid, neonatal asphyxia, neonate intensive care unit admission and small for gestational age rates were significantly increased for Group I compared with Group II (p < 0.05). In hepatitis B virus infection patients with intrahepatic cholestasis during pregnancy, elevated total serum bile acids independently correlated with six adverse pregnancy outcomes. Conclusions: Pregnant patients with both hepatitis B virus infection and intrahepatic cholestasis experienced a higher occurrence of adverse pregnancy outcomes compared to those with Hepatitis B virus infection alone. Total serum bile acids were an independent risk factor for adverse pregnancy outcomes in Hepatitis B virus infection with intrahepatic cholestasis during pregnancy. Clinical Trial Registration: The study was registered with https://classic.clinicaltrials.gov/ (no.: zx10201201).
format Article
id doaj-art-c016ba3cda2b4fc3a29bc8a18f199273
institution DOAJ
issn 0390-6663
language English
publishDate 2024-02-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-c016ba3cda2b4fc3a29bc8a18f1992732025-08-20T03:05:17ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632024-02-015123610.31083/j.ceog5102036S0390-6663(23)02197-8Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During PregnancyChong Zhang0Hong Wei1Zhiqiang Zhao2Yunxia Zhu3Departments of Obstetrics, Beijing Youan Hospital, Capital Medical University, 100069 Beijing, ChinaDepartments of Obstetrics, Beijing Youan Hospital, Capital Medical University, 100069 Beijing, ChinaDepartments of Obstetrics, Beijing Youan Hospital, Capital Medical University, 100069 Beijing, ChinaDepartments of Obstetrics, Beijing Youan Hospital, Capital Medical University, 100069 Beijing, ChinaBackground: We conducted this study to investigate adverse pregnancy outcomes of hepatitis B virus infection coexistng with intrahepatic cholestasis in pregnant women, along with identifying associated risk factors. Methods: We retrospectively collected study data from Beijing Youan Hospital in China spanning January 2014 to December 2021. The study included 220 patients, divided into two groups: Group I consisted of 110 patients with hepatitis B virus infection and intrahepatic cholestasis during pregnancy, while Group II comprised 110 patients with hepatitis B virus infection alone. Maternal demographics, laboratory values, obstetric complications, and adverse pregnancy outcomes were collected and analyzed between Groups I and II. To investigate the features of hepatitis B virus infection with intrahepatic cholestasis in pregnancy patients further, we also evaluated risk factors of adverse pregnancy outcomes in Group I. Results: Adverse pregnancy outcomes, including preterm birth (<37 weeks (w)), postpartum hemorrhage, meconium-stained amniotic fluid, neonatal asphyxia, neonate intensive care unit admission and small for gestational age rates were significantly increased for Group I compared with Group II (p < 0.05). In hepatitis B virus infection patients with intrahepatic cholestasis during pregnancy, elevated total serum bile acids independently correlated with six adverse pregnancy outcomes. Conclusions: Pregnant patients with both hepatitis B virus infection and intrahepatic cholestasis experienced a higher occurrence of adverse pregnancy outcomes compared to those with Hepatitis B virus infection alone. Total serum bile acids were an independent risk factor for adverse pregnancy outcomes in Hepatitis B virus infection with intrahepatic cholestasis during pregnancy. Clinical Trial Registration: The study was registered with https://classic.clinicaltrials.gov/ (no.: zx10201201).https://www.imrpress.com/journal/CEOG/51/2/10.31083/j.ceog5102036adverse pregnancy outcomeshepatitis b virus infectionintrahepatic cholestasis in pregnancyprognostic factorstotal serum bile acids
spellingShingle Chong Zhang
Hong Wei
Zhiqiang Zhao
Yunxia Zhu
Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
Clinical and Experimental Obstetrics & Gynecology
adverse pregnancy outcomes
hepatitis b virus infection
intrahepatic cholestasis in pregnancy
prognostic factors
total serum bile acids
title Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
title_full Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
title_fullStr Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
title_full_unstemmed Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
title_short Adverse Pregnancy Outcomes and Prognostic Factors in Hepatitis B Virus Patients with Intrahepatic Cholestasis During Pregnancy
title_sort adverse pregnancy outcomes and prognostic factors in hepatitis b virus patients with intrahepatic cholestasis during pregnancy
topic adverse pregnancy outcomes
hepatitis b virus infection
intrahepatic cholestasis in pregnancy
prognostic factors
total serum bile acids
url https://www.imrpress.com/journal/CEOG/51/2/10.31083/j.ceog5102036
work_keys_str_mv AT chongzhang adversepregnancyoutcomesandprognosticfactorsinhepatitisbviruspatientswithintrahepaticcholestasisduringpregnancy
AT hongwei adversepregnancyoutcomesandprognosticfactorsinhepatitisbviruspatientswithintrahepaticcholestasisduringpregnancy
AT zhiqiangzhao adversepregnancyoutcomesandprognosticfactorsinhepatitisbviruspatientswithintrahepaticcholestasisduringpregnancy
AT yunxiazhu adversepregnancyoutcomesandprognosticfactorsinhepatitisbviruspatientswithintrahepaticcholestasisduringpregnancy